KingKJonesDHDaltryDCCunliffeWJ. A double-blind study of the effects of 13–cis-retinoic acid on acne, sebum excretion rate and microbial population. Br J Dermatol1982; 107:583–590.
2.
JonesDHKingKMillerAJCunliffeWJ. A dose-response study of 13–cis-retinoic acid in acne vulgaris. Br J Dermatol1983; 108: 333–343.
3.
DalzielKBartonSMarksR. The effects of isotretinoin on follicular and sebaceous gland differentiation. Br J Dermatol1987; 117:317–323.
4.
GouldenVLaytonAMCunliffeWJ. Long-term safety of isotretinoin as a treatment for acne vulgaris. Br J Dermatol1994; 131:360–363.
5.
LeydenJJMcGinleyKJ. Effect of 13–cis-retinoic acid on sebum production and Propionibacterium acnes in severe nodulocystic acne. Arch Dermatol Res1982; 272:331–337.
6.
FalconRHLeeWJShalitaAR. In vitro effect of isotretinoin on monocyte Chemotaxis. J Invest Dermatol1986; 86:550–552.
7.
StraussJARapiniRPShalitaAR. Isotretinoin therapy for acne: Results of a multicentre dose-response study. J Am Acad Dermatol1984; 10:490–496.
CunliffeWJEadyEA. A reappraisal and update on the pathogenesis and treatment of acne. Curr Opin Infect Dis1992; 5:703–710.
12.
EadyEAJonesCETipperJL. Antibiotic resistant Propionibacteria in acne: Need for policies to modify usage. BMJ1993;306:555–556.
13.
EadyEACoverJHHollandKTCunliffeWJ. Superior antibacterial action and reduced incidence of bacterial resistance in minocycline compared to tetracycline-treated acne patients. Br J Dermatol1990; 122:233–244.
14.
BojarRAEadyEAJonesCE. Inhibition of erythromycin-resistant Propionibacteria on the skin of acne patients by topical erythromycin with and without zinc. Br J Dermatol1994; 130:329–336.
15.
LaytonAMHughesBRMacDonald-HullS. Seborrhoea: An indicator for poor clinical response in acne patients treated with antibiotics. Clin Exp Dermatol1992; 17:173–175.
16.
HoVSchachterDMillerR. Acne management for the 90s: Current treatment guidelines. Can J Diagn Suppl1995; 12.
17.
LaytonAMCunliffeWJ. Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol1992; 27 (Suppl):S2–S7.
18.
ShahidullahMThamSNGohCL. Isotretinoin therapy in acne vulgaris: A 10-year retrospective study in Singapore. Int J Dermatol1994; 33:60–63.
19.
SternRS. When a uniquely effective drug is teratogenic: The case of isotretinoin. N Engl J Med1989; 320:1007–1009.
20.
GouldenVLaytonAMCunliffeWJ. Current indications for isotretinoin as a treatment for acne vulgaris. Dermatology1995; 190:284–287.
21.
BurkeBMCunliffeWJ. The assessment of acne vulgaris—the Leeds technique. Br J Dermatol1984; 111:83–92.
22.
MotleyRJFinlayAY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol1992; 17:1–3.
23.
KrowchukDPStancinTKeskinenR. The psychological effects of acne on adolescents. Pediatr Dermatol1991; 8:332–338.
24.
MacDonald-HullSCunliffeWJHughesBR. Treatment of the depressed and dysmorphophobic acne patient. Clin Exp Dermatol1991;16:210–211.
RubinowDRPeckGLSquillaceKMGanttGG. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol1987; 17:25–32.
27.
ClarkSMCunliffeWJ. The use of isotretinoin in the treatment of acne in children. Br J Dermatol1995; 133(Suppl 45):39.
28.
LaytonAMHendersonCACunliffeWJ. A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol1994; 19:303–308.
29.
ParkerTLRothJGEsterlyNB. Isotretinoin for acne in Apert syndrome. Pediatr Dermatol1992; 9:298–300.
30.
GouldenV. Post adolescent acne: A review of the clinical features. Br J Dermatol (in press).
31.
BunkerCBRustinMDDowdPM. Isotretinoin treatment of severe acne in post-transplant patients taking cyclosporin. J Am Acad Dermatol1990; 22:613–614.
32.
ClarkSMCunliffeWJ. The safety of isotretinoin in the treatment of acne in patients with other systemic diseases. Br J Dermatol1996 (in press).
33.
GollnickHGraupeKDetmarMZaumseilR-P. Azelainsäure für die behandlung der akne; pharmakologie, in-vitro under in-vivo effeket, sowie klinische ergebnisse under toleranz. Z Hautkr1992; 67:975–987.
34.
PlewigGJansenTKligmanA. Pyoderma faciale—a review and report of 20 additional cases: Is it Rosacea?Arch Dermatol1992;128:1611–1617.
35.
KarvonenS. Acne fulminans: Report of clinical findings and treatment of twenty-four patients. J Am Acad Dermatol1993; 28:572–579.
36.
LeydenJJMarplesRRMillsOHJr. Gram-negative folliculitis. A complication of antibiotic therapy in acne vulgaris. Br J Dermatol1973; 88:533–538.
37.
BoerJ. Hidradenitis suppurativa or acne inversa: Long-term results of isotretinoin in the treatment of acne vulgaris. Eleventh Regional Conference of Dermatology (Asian-Australasian). Recent Trends in Dermatology, Singapore, May 1994:41.
38.
ChowETYMortimerPS. Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate. Br J Dermatol1992; 126:415–419.
39.
CunliffeWJ. Acne. London: Dunitz, 1988.
40.
KetterTAPostRMWorthingtonK. Treatment of perifolliculitis capitis abscendens et suffodiens with isotretinoin. J Dermatol Treat1992; 3:27–28.
HarmsMMasooyeIRadeffB. The relapses of cystic acne after isotretinoin treatment are age-related: A long-term follow-up study. Dermatologica1986; 172:148–153.
47.
GouldenVClarkSMCunliffeWJ. Treatment of adult acne with low dose intermittent isotretinoin. Br J Dermatol1996; 135:20.
48.
ClarkSMGouldenVCunliffeWJ. The management of acne patients who respond slowly to oral isotretinoin. Br J Dermatol1996; 135:20.
49.
PiérardGEPiérard-FranchimontCLêT. Seborrhoea in acne-prone and acne-free patients. Dermatologica1987; 175:5–9.
50.
ClarkSMCunliffeWJ. Acne flare and isotretinoin—incidence and treatment. Br J Dermatol1995; 133(Suppl 45):26.
51.
PepallLMCosgroveMPCunliffeWJ. Ablation of whiteheads by cautery under topical anaesthesia. Br J Dermatol1991; 125:256–259.
52.
WilliamsREADohertyVRPerkinsW. Staphylococcus aureus and intra-nasal mupirocin in patients receiving isotretinoin for acne. Br J Dermatol1992; 126:362–366.
53.
GriffinJP. A review of the literature on benign intracranial hypertension associated with medication. Adverse Drug React Toxicol Rev1992; 11:41–58.
54.
BarthJHMacDonald-HullSMarkJ. Isotretinoin therapy for acne vulgaris: A re-evaluation of the need for measurements of plasma lipids and liver function tests. Br J Dermatol1993; 129:704–707.
55.
BedaneCSouyriN. Les acnes induites. Ann Dermatol Venereol1990; 117:53–58.
56.
SimpsonN. Effect of isotretinoin on the quality of life patients with acne. Pharmacoeconomics1994; 6:108–113.
57.
LafargeHLevyPE. Evaluation economique d'une innovation mediamenteuse: Le traitement de l'cané sévère par Roaccutane. J Econ Med1987; 5:117–127.
58.
WishartJVilligerJ. Cost-benefit of isotretinoin (Roaccutane). N Z Med J1991; 104:193.
